Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
Dawn Q. Chong(National Cancer Centre Singapore), Paula YP Lam(National University of Singapore)
Cited by 41
Related Papers
No related papers found
Powered by citation graph analysis